Calyxt successfully produces plant-based squalene, an important ingredient in personal care products and critical vaccine adjuvants

Roseville, minn. , oct. 25, 2022 /prnewswire/ -- calyxt, inc. (nasdaq: clxt), a plant-based synthetic biology company, announced today that using a calyxt-engineered plant cell matrix™ biomass, it has successfully produced squalene, an important ingredient in many personal care products and vaccine adjuvants, including several strands of flu and covid-19 vaccines.
CLXT Ratings Summary
CLXT Quant Ranking